Stocks and Investing Stocks and Investing
Wed, September 22, 2021
[ 12:00 AM ] - WOPRAI
Stephen Manaker Initiated (AHH) at Strong Buy and Held Target at $15 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Difei Yang Maintained (BLUE) at Strong Buy with Decreased Target to $23 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Maintained (BKH) at Hold with Increased Target to $67 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Pamela Kaufman Maintained (BRBR) at Buy with Increased Target to $37 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
John Vinh Upgraded (AMBA) to Buy and Held Target at $185 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (CBRL) at Sell with Increased Target to $139 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Brian Mullan Maintained (CBRL) at Strong Buy with Decreased Target to $155 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jake Bartlett Maintained (CBRL) at Hold with Decreased Target to $152 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Daniel Imbro Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Brian Nagel Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Lavesh Hemnani Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Steven Zaccone Maintained (AZO) at Strong Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AZO) at Hold on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jay McCanless Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Joseph Altobello Upgraded (XPOF) to Strong Buy and Held Target at $14 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (VFC) at Buy with Decreased Target to $90 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Michael Rose Maintained (VBTX) at Strong Buy with Increased Target to $44 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Timna Tanners Downgraded (VALE) to Hold and Decreased Target to $20 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Steve Barger Maintained (URI) at Buy with Increased Target to $405 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Susan Roth Katzke Maintained (USB) at Hold with Increased Target to $61 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Paul Choi Downgraded (VIR) to Hold and Decreased Target to $62 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Brian Fitzgerald Initiated (VMEO) at Buy and Held Target at $47 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Oren Livnat Maintained (VRCA) at Strong Buy with Decreased Target to $20 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Scott Berg Maintained (WDAY) at Strong Buy with Increased Target to $310 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
James Goss Downgraded (TGNA) to Hold on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jackie Przybylowski Upgraded (TECK) to Buy and Increased Target to $44 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Sung Ji Nam Maintained (TMO) at Strong Buy with Increased Target to $700 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Steve Brozak Upgraded (CDTX) to Strong Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Nathan Weinstein Maintained (CDTX) at Strong Buy with Decreased Target to $160 on, Sep 22nd, 2021

Nathan Weinstein Maintained (CDTX) at Strong Buy with Decreased Target to $160 on, Sep 22nd, 2021


Published on 2024-10-27 17:57:36 - WOPRAI, Nathan Weinstein
  Print publication without navigation


Nathan Weinstein of Aegis Capital, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Decreased Target from $180 to $160 on, Sep 22nd, 2021.

Nathan, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources